Xpert MTB/RIF. Recall
Xpert MTB/RIF. Model Number: GXMTB/RIF-US-10.
FDA recall Class II
Ongoing
FDA lists this Class II recall for Xpert MTB/RIF.. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-0724-2026
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Nov 5, 2025
- FDA report date
- Dec 3, 2025
- Quantity in commerce
- 9,880 units
- Distribution
- See key details
- FDA cause
- Under Investigation by firm
What is being recalled?
Xpert MTB/RIF. Model Number: GXMTB/RIF-US-10.
Affected model & UDI checker
Search the exact identifiers published for Z-0724-2026.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| GXMTB/RIF-US-10 | Xpert MTB/RIF. | Check source notice | Not specified |
| Not specified | Xpert MTB/RIF. | Check source notice | 07332940000912 |
FDA code information
Model Number: GXMTB/RIF-US-10. UDI-DI: 07332940000912. Batch: 1000812229. Lot: 41302. Expiration Date: 2025-02-02
Why was this product recalled?
Product testing did not meet expected stability criteria.
What actions did Cepheid take?
Cephid notified consignees on about 11/05/2025 via FedEx letter. Consignees were instructed to ensure no affected units remain in inventory or are available for use since the affected lots have passed their expiration date. Past results obtained from Xpert MTB/RIF batch 1000812229 lot 41302 may be inaccurate. If these results were used to make clinical management decisions, it is recommended that the results be reviewed in the context of corresponding culture data, drug susceptibility testing, clinical presentation and other relevant laboratory information to ensure accurate patient care. If there is uncertainty or insufficient information to confirm the result, repeat testing to ensure accuracy. Consignees were requested to notify relevant clinical teams as needed. Cepheid will provide products for the purposes of retesting. Kits are expected to ship within 5 business days following receipt of the completed response form. Additionally, consignees were instructed to complete and return the Customer Response Form.
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-0724-2026
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 20, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 20, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology